Cargando…
Direct Affinity Purification of Long‐Acting PASylated Proteins with Therapeutic Potential Using L‐Prolinamide for Mild Elution
Both insufficient plasma half‐life (circulation for only few hours or less) and laborious downstream purification can be bottleneck for biological drug development. We report a novel strategy for the efficient and gentle affinity purification of pharmacologically relevant proteins modified by PASyla...
Autores principales: | Schilz, Jonas, Clement, Charlotte, Greiner, Franziska, Skerra, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320812/ https://www.ncbi.nlm.nih.gov/pubmed/35325504 http://dx.doi.org/10.1002/anie.202200079 |
Ejemplares similares
-
PASylated Thymosin α1: A Long-Acting Immunostimulatory Peptide for Applications in Oncology and Virology
por: Binder, Uli, et al.
Publicado: (2020) -
PASylation: a biological alternative to PEGylation for extending the
plasma half-life of pharmaceutically active proteins
por: Schlapschy, Martin, et al.
Publicado: (2013) -
High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation
por: Mendler, Claudia T, et al.
Publicado: (2014) -
Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo
por: Peplau, Emanuel, et al.
Publicado: (2021) -
Improvement of Certolizumab Fab′ properties by PASylation technology
por: Mazaheri, Somayeh, et al.
Publicado: (2020)